ENTYVIO® (vedolizumab) for Ulcerative Colitis and Crohn's Disease
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
Infusions and Subcutaneous Injections | ENTYVIO® (vedolizumab)
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
Achieve Results with ENTYVIO® Treatment for Ulcerative Colitis
ENTYVIO (vedolizumab) helps control gastrointestinal inflammation in adults with moderate to severe ulcerative colitis. See Safety and Prescribing Information.
ENTYVIO® (vedolizumab) Side Effects
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
What Is ENTYVIO®? | Crohn's and UC Biologic Treatment
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
ENTYVIO® (vedolizumab) Cost & Co-Pay Assistance
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
ENTYVIO® (vedolizumab) Frequently Asked Questions
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
Resources for Patients | ENTYVIO® (vedolizumab)
intravenous (IV) infusion: 300 mg vedolizumab. subcutaneous (SC) injection: 108 mg vedolizumab. You are encouraged to report negative side effects of prescription drugs to the FDA.
ENTYVIO® (en ti’ vee oh) PEN (vedolizumab) injection, for subcutaneous use Single-dose prefilled pen This Instructions for Use contains information on how to inject ENTYVIO. SELECTED SAFETY INFORMATION Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any of its ingredients. ENTYVIO may cause serious side effects
Achieve Results With ENTYVIO® Treatment for Crohn's Disease
ENTYVIO (vedolizumab) helps control gastrointestinal inflammation in adults with moderate to severe Crohn's disease. See Safety and Prescribing Information.